The US Food and Drug Administration (FDA) has appointed George Tidmarsh, a former biotech executive, as its top drug regulator. Tidmarsh will lead the Center for Drug Evaluation and Research, which reviews most new drug applications. His appointment comes after Jacqueline Corrigan-Curay, acting head of CDER, left the agency.
Source: https://www.bloomberg.com/news/articles/2025-07-21/fda-to-name-biotech-executivey-george-tidmarsh-as-rfk-jr-s-top-drug-regulator